2,5-Second Bromotoluene( CAS 615-59-8) Market Size, Share, Growth, Cost and Price, Analysis, Key Trends and Opportunities Forecasts 2016
2,5-Second Bromotoluene( CAS 615-59-8) Market Size, Share, Growth, Cost and Price, Analysis, Key Trends and Opportunities Forecasts 2016
Summary GBI Research’ s latest report, "" Strategic Trends in Private Equity and Venture Capital Funding for Healthcare "" provides a comprehensive analysis on emerging investment trends within the healthcare industry. Private equity( PE) and venture capital( VC) funds have been important participants in a wide range of industries for many decades- particularly the healthcare industry. They remain one of the few sources of funding for innovative startup companies, which often bring disruptive technologies and life-saving medical interventions to the market.
This report provides in-depth qualitative and quantitative analyses of global and regional trends that have shaped the current healthcare PE and VC landscape, particularly from 2006 to 2015. It provides multilevel analyses that identify geographical markets and therapy areas attracting noteworthy investments. Analyses of key investment indicators in the US, including levels of fundraising activities by PE and VC companies, VC investments by industry sector, and VC-backed exits and venture financing trends- particularly for early-stage healthcare companies- are also included.
Read Complete Report with TOC @ http:// www. radiantinsights. com / research / strategic-trends-in-privateequity-and-venture-capital-funding-for-healthcare
Information from our robust, industry-leading databases shows that global values of completed equity offerings in the healthcare industry are continuing their upward trend, reaching record highs in recent years. Quantitative analyses of equity offerings in the healthcare sector from 2006 to 2015 are provided alongside trends in healthcare VC-backed initial public offerings( IPOs) in the US. Top healthcare IPOs are reviewed in detail, with company profiles that include product pipelines showing therapy areas of focus, indications and product development stages.
The report also includes forecasts for the outlook for PE and VC firms investing in the healthcare sector. VC investment in early-stage healthcare companies continues to decline, and has almost completely disappeared in certain countries. The report discusses new financing models that are emerging and replacing traditional VC financing models, including case studies showcasing recent success stories.
GBI Research conducted extensive research in order to provide a comprehensive view of the strategic trends in PE and VC funding for healthcare.
This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.